Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING TUBERCULOSIS, CONTAINING Β-GLUCAN AND ANTITUBERCULOUS DRUG AS ACTIVE INGREDIENTS
Document Type and Number:
WIPO Patent Application WO/2018/124386
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing and treating tuberculosis, containing β-glucan and an anti-tuberculous drug as active ingredients. More specifically, the present invention provides a pharmaceutical composition for preventing and treating tuberculosis and for performing co-treatment with an anti-tuberculous drug and β-glucan isolated from Schizophyllum commune.
Inventors:
LEE JONG DAE (KR)
KIM JE KYOUNG (KR)
JANG YONG MAN (KR)
KIM MIN JI (KR)
PARK EUN JI (KR)
YANG CHUL SU (KR)
KIM JE KYOUNG (KR)
JANG YONG MAN (KR)
KIM MIN JI (KR)
PARK EUN JI (KR)
YANG CHUL SU (KR)
Application Number:
PCT/KR2017/002154
Publication Date:
July 05, 2018
Filing Date:
February 27, 2017
Export Citation:
Assignee:
QUEGEN BIOTECH CO LTD (KR)
International Classes:
A61K31/716; A23L33/10; A61K31/7036; A61K36/07; A61K45/06
Foreign References:
| KR100295623B1 | 2001-09-06 | |||
| US20090023681A1 | 2009-01-22 |
Other References:
SOTO, ERNESTO: "Glucan particle encapsulated rifampicin for targeted delivery to macrophages", POLYMERS, vol. 2, 2010, pages 681 - 689, XP055612939
HETLAND, GEIR: "beta -1, 3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures", FEMS IMMUNOLOGY & MEDICAL MICROBIOLOGY, vol. 33, 2002, pages 41 - 45, XP055612944
RAMON-GARCIA, SANTIAGO: "Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 55, no. 8, 2011, pages 3861 - 3869, XP055059891
HETLAND, GEIR: "beta -1, 3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures", FEMS IMMUNOLOGY & MEDICAL MICROBIOLOGY, vol. 33, 2002, pages 41 - 45, XP055612944
RAMON-GARCIA, SANTIAGO: "Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 55, no. 8, 2011, pages 3861 - 3869, XP055059891
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF:
Previous Patent: POLYURETHANE MIDSOLE FOR SHOE AND MANUFACTURING METHOD THEREFOR
Next Patent: LARYNGEAL MASK AIRWAY FOR SEDATIVE ENDOSCOPY
Next Patent: LARYNGEAL MASK AIRWAY FOR SEDATIVE ENDOSCOPY